ORIGINAL ARTICLESSystemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
References (0)
Cited by (0)
- 1
Collaborators are listed at the end of the report. Correspondence. EBCTCG Secretariat, ICRF/MRC Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford 0X2 6HE, UK
Copyright © 1992 Published by Elsevier Ltd.